You just read:

PRIVIGEN® (Immune Globulin Intravenous (Human), 10% Liquid) Granted Orphan-Drug Designation for the Investigational Treatment of Systemic Sclerosis (SSc)

News provided by

CSL Behring

Feb 11, 2020, 17:10 ET